Deutsche Bank anticipates the upcoming crucial week for Lorillard LO.
According to Deutsche Bank, “A critical few days ahead for menthol as TPSAC readies its report to FDA. Final TPSAC meeting March 17-18 may reveal recommendations, otherwise we look to the March 23 report date. We remain neutral on LO. Stock is discounting significant risk of a ban. Nonetheless negative TPSAC recommendations could pressure near-term valuation and long-term regulation, as FDA's stance on the issue remains opaque.”
LO has a Hold Rating and an $87 PT.
LO closed at $78.26 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.